Scientists have identified a ‘molecular barcode’ in the blood of patients with Ebola that can predict whether they are likely to survive or die from the viral infection. Scientists have used blood samples taken from infected and recovering patients during the 2013-2016 West Africa outbreak to identify gene products that act as strong predictors of patient outcome.